{"name":"TargeGen","slug":"targegen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNb2NjUGhucjgxeGVub1BaOVpWRWFzTVVLSzZob0d6QzZ3WVJSdzBJdGJDUFNuQkVMams1OWJneUhDZVdJTFJ1dVo5N05iQlVqcHJsWkU5blhYeVl3aWF5LU1XQjB2eTEwZHRWR3lHd2h1N2plXzRMLTNCRzV0S280LTZDZF9HejNfOUxzVm8xWTNYOG1sYVJJVUFsaTgwdmY1OUdsY3prbENaS29RQmVYRXdkZ3M?oc=5","date":"2019-08-16","type":"regulatory","source":"Fierce Pharma","summary":"In a boon for buyer Bristol-Myers, Celgene's JAK med Inrebic scores FDA nod - Fierce Pharma","headline":"In a boon for buyer Bristol-Myers, Celgene's JAK med Inrebic scores FDA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNX2lsblpYWGJtQzhBa2Iza1Y3MFVEdUtIdkFSWUxhWkFHUVBmbUhOdDZRaE5vR1hxeVJ5REN6T21ReVowRHVrUnphY0pvRHJSQnhURWFyX2VUVWlNRlV0X0xxZ19rcWNyQ3hmcEFFSzVQZ1VkWEx3MW94dzg5bVJPR09LZ2ZheFYzd3NZSXF4bl8wLXpoSGJ4Qk81NE4wTWdfMHY1REs5TjRocjlubUU4?oc=5","date":"2018-01-08","type":"deal","source":"Fierce Biotech","summary":"J.P. Morgan kicks off with a deal as Celgene pays $1.1B for Impact Biomedicines - Fierce Biotech","headline":"J.P. Morgan kicks off with a deal as Celgene pays $1.1B for Impact Biomedicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOU1JydEtyRGpxMU43dVRwWmpXcUxjYjhtV0wzZG1HN2RxVWNmQUxvcVZrd2VOaFd2WmZVSVdJcTl6cGhVZXFnUEtvVGYzdG9YQ0tzU296cXk2aHV1ZTE4aDZFZHZIM0hkLXFRTGF6NGxQRDBhS1ZuY0owajZZdlA4QzRkUHpPVTdHdXlsb1JGcEdoZ3JZQ0lVU0VnTk03TUtJNjlqSzVCYjV4TEswLXd2SE8xS2JGWFRDUGdYakFQVkVKWUsxU1RBNG9nVDlWUEltRHBv?oc=5","date":"2017-10-13","type":"pipeline","source":"Forbes","summary":"Big Pharma Killed The Cancer Drug He Invented. He Raised $22 Million To Revive It - Forbes","headline":"Big Pharma Killed The Cancer Drug He Invented. He Raised $22 Million To Revive It","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}